The increasing prevalence of prostate cancer and the growing need for advanced oncology solutions have accelerated the development of innovative mCRPC treatment, next-generation prostate cancer therapeutics, and improved androgen deprivation therapy approaches. Metastatic castration-resistant prostate cancer (mCRPC) represents an advanced stage of prostate cancer where the disease continues to...